Innovation Pharmaceuticals Inc
OTC:IPIX
Innovation Pharmaceuticals Inc
OTC:IPIX
Price:
0.0003
USD
50%
Market Closed
Market Cap:
$46.1k
Balance Sheet
Balance Sheet Decomposition
Innovation Pharmaceuticals Inc
Innovation Pharmaceuticals Inc
Balance Sheet Decomposition is not available for
Innovation Pharmaceuticals Inc
Innovation Pharmaceuticals Inc
Balance Sheet
Innovation Pharmaceuticals Inc
Innovation Pharmaceuticals Inc
Currency: USD
| Jun-2006 | Jun-2007 | Jun-2008 | Jun-2009 | Jun-2010 | Jun-2011 | Jun-2012 | Jun-2013 | Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
5
|
8
|
6
|
4
|
2
|
1
|
6
|
10
|
4
|
2
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
5
|
8
|
6
|
4
|
2
|
1
|
6
|
10
|
4
|
2
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
6
|
9
|
7
|
4
|
3
|
1
|
6
|
11
|
4
|
2
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
5
|
4
|
4
|
4
|
3
|
3
|
3
|
2
|
2
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
4
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
N/A
|
0
+2 150%
|
0
-64%
|
0
-38%
|
0
+210%
|
0
-90%
|
3
+9 800%
|
11
+265%
|
14
+32%
|
11
-20%
|
9
-20%
|
7
-28%
|
4
-38%
|
9
+129%
|
14
+55%
|
10
-27%
|
8
-28%
|
|
| Liabilities | |||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
1
|
2
|
2
|
2
|
3
|
2
|
4
|
5
|
3
|
2
|
2
|
3
|
3
|
3
|
|
| Accrued Liabilities |
0
|
0
|
0
|
1
|
2
|
2
|
3
|
4
|
4
|
3
|
3
|
4
|
3
|
3
|
3
|
3
|
2
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
1
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
2
|
5
|
7
|
7
|
8
|
10
|
7
|
8
|
11
|
9
|
7
|
7
|
7
|
5
|
5
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
N/A
|
1
+8 000%
|
2
+141%
|
5
+151%
|
8
+55%
|
8
+1%
|
8
+6%
|
10
+19%
|
7
-24%
|
8
+16%
|
11
+25%
|
9
-18%
|
8
-6%
|
8
-5%
|
7
-13%
|
6
-17%
|
5
-3%
|
|
| Equity | |||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
0
|
1
|
2
|
5
|
11
|
16
|
20
|
28
|
41
|
54
|
70
|
86
|
95
|
101
|
115
|
122
|
125
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
1
|
5
|
9
|
15
|
29
|
48
|
57
|
68
|
84
|
91
|
103
|
125
|
129
|
130
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
|
| Total Equity |
0
N/A
|
0
N/A
|
0
N/A
|
2
-397%
|
5
-168%
|
7
-52%
|
8
-5%
|
5
+32%
|
1
N/A
|
7
+480%
|
3
-58%
|
1
N/A
|
2
-47%
|
4
-92%
|
1
N/A
|
8
+414%
|
5
-37%
|
2
-57%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
N/A
|
0
+2 150%
|
0
-64%
|
0
-38%
|
0
+210%
|
0
-90%
|
3
+9 800%
|
11
+265%
|
14
+32%
|
11
-20%
|
9
-20%
|
7
-28%
|
4
-38%
|
9
+129%
|
14
+55%
|
10
-27%
|
8
-28%
|
|
| Shares Outstanding | |||||||||||||||||||
| Common Shares Outstanding |
10
|
10
|
92
|
92
|
92
|
88
|
92
|
99
|
110
|
118
|
124
|
135
|
163
|
203
|
331
|
434
|
504
|
518
|
|
Switch to:
Switch to:
See Also
Discover More
